36 min listen
10/17/22: Long-dreaded countdown at AbbVie
ratings:
Length:
26 minutes
Released:
Oct 14, 2022
Format:
Podcast episode
Description
In just three months, AbbVie’s leading product, Humira, will face biosimilar competition in the U.S. for the first time. Crain’s health care reporter Katherine Davis talks with host Amy Guth about what the future might look like for the drugmaker.
Plus: Mariano's parent to buy Jewel-Osco owner, AT&T cuts deal in Madigan case as former exec charged, downtown office vacancy inches back up to record high, and Gov. J.B. Pritzker and his challenger Darren Bailey individually met with Crain's editorial board to discuss their respective visions for the state.
Plus: Mariano's parent to buy Jewel-Osco owner, AT&T cuts deal in Madigan case as former exec charged, downtown office vacancy inches back up to record high, and Gov. J.B. Pritzker and his challenger Darren Bailey individually met with Crain's editorial board to discuss their respective visions for the state.
Released:
Oct 14, 2022
Format:
Podcast episode
Titles in the series (100)
05/20/21: As prices explode, should you buy a home?: Low mortgage rates and a shortage of properties for sale has caused home prices to skyrocket. Do new homebuyers stand to lose money in the long run by buying in a sellers’ market? Dennis Rodkin joins host Amy Guth to recap this week’s real estate news and take listener questions. Plus: Agents group sues Allstate for multiple breaches of contract, WeWork chairman says demand for shared office space exceeds pre-pandemic levels, market research firm Ipsos reduces its downtown footprint, and Bank of America will raise minimum wage to $25 an hour. by Crain's Daily Gist